Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.

Botulinum Toxins, Type A / therapeutic use Cerebral Palsy / drug therapy Child Child, Preschool Female Humans Injections, Intramuscular Male Muscle Spasticity / drug therapy Muscle, Skeletal / drug effects Neuromuscular Agents / therapeutic use Treatment Outcome
3D freehand ultrasound botulinum neurotoxin type-A muscle growth rate spastic cerebral palsy

Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
14 02 2022
Historique:
received: 22 01 2022
accepted: 10 02 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 19 3 2022
Statut: epublish

Résumé

Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment in spastic cerebral palsy (SCP). Despite improved clinical outcomes, concerns regarding harmful effects on muscle morphology have been raised. Yet, the risk of initiating BoNT-A to reduce muscle growth remains unclear. This study investigated medial gastrocnemius (MG) morphological muscle growth in children with SCP (

Identifiants

DOI: 10.3390/toxins14020139 PMID: 35202166 PMC: PMC8876834
pubmed: 35202166
pii: toxins14020139
doi: 10.3390/toxins14020139
pmc: PMC8876834
pii:
doi:

Substances chimiques

Neuromuscular Agents 0
Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Biomech. 2011 Jan 4;44(1):39-44
pubmed: 20828699
Front Neurol. 2021 Feb 18;12:620852
pubmed: 33679586
Cochrane Database Syst Rev. 2019 Oct 08;10:CD001408
pubmed: 31591703
Phys Med Rehabil Clin N Am. 2015 Feb;26(1):57-67
pubmed: 25479779
Gait Posture. 2012 Jan;35(1):154-8
pubmed: 21930383
Dev Med Child Neurol. 2011 Jun;53(6):543-8
pubmed: 21506995
Eur J Paediatr Neurol. 2010 Jan;14(1):45-66
pubmed: 19914110
Muscle Nerve. 2016 Jun;53(6):933-45
pubmed: 26565390
Muscle Nerve. 2016 Mar;53(3):407-14
pubmed: 26154631
Dev Med Child Neurol. 2018 Jan;60(1):81-87
pubmed: 29067675
J Orthop Sci. 2018 Mar;23(2):389-393
pubmed: 29146092
Ultrasound Med Biol. 2009 Mar;35(3):443-6
pubmed: 19081667
Dev Med Child Neurol. 2018 Jul;60(7):672-679
pubmed: 29573407
Muscle Nerve. 2015 Dec;52(6):963-71
pubmed: 25787260
Dev Med Child Neurol. 2010 Sep;52(9):794-804
pubmed: 20477832
Dev Med Child Neurol. 2008 Oct;50(10):744-50
pubmed: 18834387
Muscle Nerve. 2000 Nov;23(11):1647-66
pubmed: 11054744
Eur J Neurol. 2010 Aug;17 Suppl 2:9-37
pubmed: 20633177
Ultrasound Med Biol. 2017 Dec;43(12):2814-2823
pubmed: 28967503
Gait Posture. 2004 Oct;20(2):177-82
pubmed: 15336288
Eur J Paediatr Neurol. 2009 Sep;13(5):421-9
pubmed: 18977158
J Child Orthop. 2013 Nov;7(5):425-33
pubmed: 24432106
Phys Ther. 1987 Feb;67(2):206-7
pubmed: 3809245
Muscle Nerve. 2018 Dec;58(6):818-823
pubmed: 29981242
Muscle Nerve. 2018 Mar;57(3):435-441
pubmed: 28556093
Mov Disord. 2009 Jul 30;24(10):1494-503
pubmed: 19489066
Med Image Anal. 1999 Jun;3(2):141-73
pubmed: 10711996
J Bone Joint Surg Br. 2003 Mar;85(2):157-66
pubmed: 12678344
J Biomech. 2014 Feb 07;47(3):631-8
pubmed: 24368144
Curr Osteoporos Rep. 2020 Feb;18(1):47-56
pubmed: 32060718
Dev Med Child Neurol. 2012 Jun;54(6):495-9
pubmed: 22364585
Drug Chem Toxicol. 2007;30(3):217-27
pubmed: 17613007
J Biomech. 2018 Aug 22;77:194-200
pubmed: 29935732
Paediatr Drugs. 2019 Aug;21(4):261-281
pubmed: 31257556
J Pediatr Orthop. 2004 Sep-Oct;24(5):514-20
pubmed: 15308901
J Bone Joint Surg Am. 2006 Jan;88(1):161-70
pubmed: 16391261
Dev Med Child Neurol. 2018 Nov;60(11):1165-1171
pubmed: 30151852
Nat Rev Dis Primers. 2016 Jan 07;2:15082
pubmed: 27188686
Disabil Rehabil. 2015;37(7):579-84
pubmed: 24989066
Dev Med Child Neurol. 2019 Jul;61(7):783-790
pubmed: 30320442
Front Neurol. 2020 Apr 21;11:210
pubmed: 32373040
Dev Med Child Neurol. 2006 May;48(5):399
pubmed: 16608552
Acta Orthop. 2019 Jun;90(3):286-291
pubmed: 30907682
Eur J Pediatr. 2019 Jun;178(6):811-822
pubmed: 30877384
Ultrasound Med Biol. 2021 Sep;47(9):2702-2712
pubmed: 34112554
Dev Med Child Neurol. 2021 Mar;63(3):263-273
pubmed: 33107594
Dev Med Child Neurol. 2016 May;58(5):485-91
pubmed: 26510820
Muscle Nerve. 2012 Sep;46(3):360-6
pubmed: 22907226
Res Dev Disabil. 2013 Mar;34(3):1052-8
pubmed: 23295965
J Child Orthop. 2013 Nov;7(5):383-7
pubmed: 24432099
Dev Med Child Neurol. 2013 Sep;55(9):813-20
pubmed: 23789782
Yonsei Med J. 2014 Sep;55(5):1406-12
pubmed: 25048504
Dev Med Child Neurol. 2011 Mar;53(3):210-6
pubmed: 21291464
JBJS Rev. 2019 Aug;7(8):e4
pubmed: 31415277
Sci Rep. 2017 Nov 7;7(1):14746
pubmed: 29116170

Auteurs

Nathalie De Beukelaer (N)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
ORCID: 0000-0002-7800-3354

Guido Weide (G)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
Laboratory for Myology, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, 1081 Amsterdam, The Netherlands.

Ester Huyghe (E)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.

Ines Vandekerckhove (I)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.

Britta Hanssen (B)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
Department of Rehabilitation Science, Ghent University, 9000 Ghent, Belgium.
ORCID: 0000-0003-0406-6050

Nicky Peeters (N)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
Department of Rehabilitation Science, Ghent University, 9000 Ghent, Belgium.
ORCID: 0000-0003-0380-9174

Julie Uytterhoeven (J)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.

Jorieke Deschrevel (J)

Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.

Karen Maes (K)

Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.

Marlies Corvelyn (M)

Stem Cell Biology and Embryology, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
ORCID: 0000-0001-8460-3789

Domiziana Costamagna (D)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
Stem Cell Biology and Embryology, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.

Ghislaine Gayan-Ramirez (G)

Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.

Anja Van Campenhout (A)

Unit of Pediatric Orthopedics, Department of Orthopedics, University Hospitals Leuven, 3000 Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Clinical Motion Analysis Laboratory, University Hospitals Leuven, Pellenberg, 3212 Leuven, Belgium.
ORCID: 0000-0002-8158-5535

Kaat Desloovere (K)

Neurorehabilitation Group, Department of Rehabilitation Sciences, KU Leuven, 3000 Leuven, Belgium.
Clinical Motion Analysis Laboratory, University Hospitals Leuven, Pellenberg, 3212 Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Toxines bactériennes › Toxines botuliniques › Toxines botuliniques de type A › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Encéphalopathies › Paralysie cérébrale › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Injections › Injections musculaires › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Manifestations neuromusculaires › Hypertonie musculaire › Spasticité musculaire › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Tissus › Muscles › Muscle strié › Muscles squelettiques › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents du système nerveux périphérique › Agents neuromusculaires › Reduced Cross-Sectional Muscle Growth Six...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Reduced Cross-Sectional Muscle Growth Six...